Structural biology and functional features of phage-derived depolymerase Depo32 on Klebsiella pneumoniae with K2 serotype capsular polysaccharides
ABSTRACT Hypervirulent Klebsiella pneumoniae with capsular polysaccharides (CPSs) causes severe nosocomial- and community-acquired infections. Phage-derived depolymerases can degrade CPSs from K. pneumoniae to attenuate bacterial virulence, but their antimicrobial mechanisms and clinical potential a...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2023-10-01
|
Series: | Microbiology Spectrum |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/spectrum.05304-22 |
_version_ | 1797658249162391552 |
---|---|
author | Ruopeng Cai Zhuolu Ren Rihong Zhao Yan Lu Xinwu Wang Zhimin Guo Jinming Song Wentao Xiang Rui Du Xiaokang Zhang Wenyu Han Heng Ru Jingmin Gu |
author_facet | Ruopeng Cai Zhuolu Ren Rihong Zhao Yan Lu Xinwu Wang Zhimin Guo Jinming Song Wentao Xiang Rui Du Xiaokang Zhang Wenyu Han Heng Ru Jingmin Gu |
author_sort | Ruopeng Cai |
collection | DOAJ |
description | ABSTRACT Hypervirulent Klebsiella pneumoniae with capsular polysaccharides (CPSs) causes severe nosocomial- and community-acquired infections. Phage-derived depolymerases can degrade CPSs from K. pneumoniae to attenuate bacterial virulence, but their antimicrobial mechanisms and clinical potential are not well understood. In the present study, Klebsiella phage GH-K3-derived depolymerase Depo32 (encoded by gene gp32) was identified to exhibit high efficiency in specifically degrading the CPSs of K2 serotype K. pneumoniae. The cryo-electron microscopy structure of trimeric Depo32 at a resolution up to 2.32 Å revealed potential catalytic centers in the cleft of each of the two adjacent subunits. K. pneumoniae subjected to Depo32 became more sensitive to phagocytosis by RAW264.7 cells and activated the cells by the mitogen-activated protein kinase signaling pathway. In addition, intranasal inoculation with Depo32 (a single dose of 200 µg, 20 µg daily for 3 days, or in combination with gentamicin) rescued all C57BL/6J mice infected with a lethal dose of K. pneumoniae K7 without interference from its neutralizing antibody. In summary, this work elaborates on the mechanism by which Depo32 targets the degradation of K2 serotype CPSs and its potential as an antivirulence agent. IMPORTANCE Depolymerases specific to more than 20 serotypes of Klebsiella spp. have been identified, but most studies only evaluated the single-dose treatment of depolymerases with relatively simple clinical evaluation indices and did not reveal the anti-infection mechanism of these depolymerases in depth. On the basis of determining the biological characteristics, the structure of Depo32 was analyzed by cryo-electron microscopy, and the potential active center was further identified. In addition, the effects of Depo32 on macrophage phagocytosis, signaling pathway activation, and serum killing were revealed, and the efficacy of the depolymerase (single treatment, multiple treatments, or in combination with gentamicin) against acute pneumonia caused by Klebsiella pneumoniae was evaluated. Moreover, the roles of the active sites of Depo32 were also elucidated in the in vitro and in vivo studies. Therefore, through structural biology, cell biology, and in vivo experiments, this study demonstrated the mechanism by which Depo32 targets K2 serotype K. pneumoniae infection. |
first_indexed | 2024-03-11T17:56:31Z |
format | Article |
id | doaj.art-d0c0e75a311e485ca00b43fe3055bb63 |
institution | Directory Open Access Journal |
issn | 2165-0497 |
language | English |
last_indexed | 2024-03-11T17:56:31Z |
publishDate | 2023-10-01 |
publisher | American Society for Microbiology |
record_format | Article |
series | Microbiology Spectrum |
spelling | doaj.art-d0c0e75a311e485ca00b43fe3055bb632023-10-17T13:04:35ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972023-10-0111510.1128/spectrum.05304-22Structural biology and functional features of phage-derived depolymerase Depo32 on Klebsiella pneumoniae with K2 serotype capsular polysaccharidesRuopeng Cai0Zhuolu Ren1Rihong Zhao2Yan Lu3Xinwu Wang4Zhimin Guo5Jinming Song6Wentao Xiang7Rui Du8Xiaokang Zhang9Wenyu Han10Heng Ru11Jingmin Gu12College of Animal Science and Technology, Jilin Agricultural University , Changchun, Jilin, ChinaZhejiang Provincial Key Laboratory for Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University , Hangzhou, Zhejiang, ChinaCollege of Veterinary Medicine, Jilin University , Changchun, Jilin, ChinaCollege of Veterinary Medicine, Jilin University , Changchun, Jilin, ChinaCollege of Animal Science and Technology, Jilin Agricultural Science and Technology University , Changchun, Jilin, ChinaInfectious Diseases and Pathogen Biology Center, Clinical Laboratory Department, First Hospital of Jilin University , Changchun, Jilin, ChinaCollege of Animal Science and Technology, Jilin Agricultural University , Changchun, Jilin, ChinaCollege of Animal Science and Technology, Jilin Agricultural University , Changchun, Jilin, ChinaCollege of Animal Science and Technology, Jilin Agricultural University , Changchun, Jilin, ChinaFaculty of Life and Health Sciences, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences , Shenzhen, Guangdong, ChinaCollege of Veterinary Medicine, Jilin University , Changchun, Jilin, ChinaZhejiang Provincial Key Laboratory for Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University , Hangzhou, Zhejiang, ChinaCollege of Veterinary Medicine, Jilin University , Changchun, Jilin, ChinaABSTRACT Hypervirulent Klebsiella pneumoniae with capsular polysaccharides (CPSs) causes severe nosocomial- and community-acquired infections. Phage-derived depolymerases can degrade CPSs from K. pneumoniae to attenuate bacterial virulence, but their antimicrobial mechanisms and clinical potential are not well understood. In the present study, Klebsiella phage GH-K3-derived depolymerase Depo32 (encoded by gene gp32) was identified to exhibit high efficiency in specifically degrading the CPSs of K2 serotype K. pneumoniae. The cryo-electron microscopy structure of trimeric Depo32 at a resolution up to 2.32 Å revealed potential catalytic centers in the cleft of each of the two adjacent subunits. K. pneumoniae subjected to Depo32 became more sensitive to phagocytosis by RAW264.7 cells and activated the cells by the mitogen-activated protein kinase signaling pathway. In addition, intranasal inoculation with Depo32 (a single dose of 200 µg, 20 µg daily for 3 days, or in combination with gentamicin) rescued all C57BL/6J mice infected with a lethal dose of K. pneumoniae K7 without interference from its neutralizing antibody. In summary, this work elaborates on the mechanism by which Depo32 targets the degradation of K2 serotype CPSs and its potential as an antivirulence agent. IMPORTANCE Depolymerases specific to more than 20 serotypes of Klebsiella spp. have been identified, but most studies only evaluated the single-dose treatment of depolymerases with relatively simple clinical evaluation indices and did not reveal the anti-infection mechanism of these depolymerases in depth. On the basis of determining the biological characteristics, the structure of Depo32 was analyzed by cryo-electron microscopy, and the potential active center was further identified. In addition, the effects of Depo32 on macrophage phagocytosis, signaling pathway activation, and serum killing were revealed, and the efficacy of the depolymerase (single treatment, multiple treatments, or in combination with gentamicin) against acute pneumonia caused by Klebsiella pneumoniae was evaluated. Moreover, the roles of the active sites of Depo32 were also elucidated in the in vitro and in vivo studies. Therefore, through structural biology, cell biology, and in vivo experiments, this study demonstrated the mechanism by which Depo32 targets K2 serotype K. pneumoniae infection.https://journals.asm.org/doi/10.1128/spectrum.05304-22depolymeraseKlebsiella pneumoniaeK2 capsular typestructural biologytherapeutic effect |
spellingShingle | Ruopeng Cai Zhuolu Ren Rihong Zhao Yan Lu Xinwu Wang Zhimin Guo Jinming Song Wentao Xiang Rui Du Xiaokang Zhang Wenyu Han Heng Ru Jingmin Gu Structural biology and functional features of phage-derived depolymerase Depo32 on Klebsiella pneumoniae with K2 serotype capsular polysaccharides Microbiology Spectrum depolymerase Klebsiella pneumoniae K2 capsular type structural biology therapeutic effect |
title | Structural biology and functional features of phage-derived depolymerase Depo32 on Klebsiella pneumoniae with K2 serotype capsular polysaccharides |
title_full | Structural biology and functional features of phage-derived depolymerase Depo32 on Klebsiella pneumoniae with K2 serotype capsular polysaccharides |
title_fullStr | Structural biology and functional features of phage-derived depolymerase Depo32 on Klebsiella pneumoniae with K2 serotype capsular polysaccharides |
title_full_unstemmed | Structural biology and functional features of phage-derived depolymerase Depo32 on Klebsiella pneumoniae with K2 serotype capsular polysaccharides |
title_short | Structural biology and functional features of phage-derived depolymerase Depo32 on Klebsiella pneumoniae with K2 serotype capsular polysaccharides |
title_sort | structural biology and functional features of phage derived depolymerase depo32 on klebsiella pneumoniae with k2 serotype capsular polysaccharides |
topic | depolymerase Klebsiella pneumoniae K2 capsular type structural biology therapeutic effect |
url | https://journals.asm.org/doi/10.1128/spectrum.05304-22 |
work_keys_str_mv | AT ruopengcai structuralbiologyandfunctionalfeaturesofphagederiveddepolymerasedepo32onklebsiellapneumoniaewithk2serotypecapsularpolysaccharides AT zhuoluren structuralbiologyandfunctionalfeaturesofphagederiveddepolymerasedepo32onklebsiellapneumoniaewithk2serotypecapsularpolysaccharides AT rihongzhao structuralbiologyandfunctionalfeaturesofphagederiveddepolymerasedepo32onklebsiellapneumoniaewithk2serotypecapsularpolysaccharides AT yanlu structuralbiologyandfunctionalfeaturesofphagederiveddepolymerasedepo32onklebsiellapneumoniaewithk2serotypecapsularpolysaccharides AT xinwuwang structuralbiologyandfunctionalfeaturesofphagederiveddepolymerasedepo32onklebsiellapneumoniaewithk2serotypecapsularpolysaccharides AT zhiminguo structuralbiologyandfunctionalfeaturesofphagederiveddepolymerasedepo32onklebsiellapneumoniaewithk2serotypecapsularpolysaccharides AT jinmingsong structuralbiologyandfunctionalfeaturesofphagederiveddepolymerasedepo32onklebsiellapneumoniaewithk2serotypecapsularpolysaccharides AT wentaoxiang structuralbiologyandfunctionalfeaturesofphagederiveddepolymerasedepo32onklebsiellapneumoniaewithk2serotypecapsularpolysaccharides AT ruidu structuralbiologyandfunctionalfeaturesofphagederiveddepolymerasedepo32onklebsiellapneumoniaewithk2serotypecapsularpolysaccharides AT xiaokangzhang structuralbiologyandfunctionalfeaturesofphagederiveddepolymerasedepo32onklebsiellapneumoniaewithk2serotypecapsularpolysaccharides AT wenyuhan structuralbiologyandfunctionalfeaturesofphagederiveddepolymerasedepo32onklebsiellapneumoniaewithk2serotypecapsularpolysaccharides AT hengru structuralbiologyandfunctionalfeaturesofphagederiveddepolymerasedepo32onklebsiellapneumoniaewithk2serotypecapsularpolysaccharides AT jingmingu structuralbiologyandfunctionalfeaturesofphagederiveddepolymerasedepo32onklebsiellapneumoniaewithk2serotypecapsularpolysaccharides |